TAREK ELGHANDOUR: Open Payments
NPI 1134619893 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 8 payments from 6 companies in 2025. Trend: 2023 $200 · 2024 $283 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $83 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
| BridgeBio Pharma, Inc. | 1 | $26 |
| Melinta Therapeutics, LLC | 1 | $24 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: JARDIANCE, TERLIVAZ, Attruby, Rezzayo, ISTURISA, LOKELMA.
Industry payments across NY — which companies pay providers there.
